生存期-话题@MedSci

#生存期#

350篇内容 | 3622人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1378149, encodeId=7d9c13e8149a7, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Lancet Oncol：来曲唑治疗方案对早期乳腺癌患者无进展生存期的影响, objectType=article, longId=120823, objectId=c0e612082300, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e612082300, replyNumber=0, likeNumber=76, createdTime=2017-11-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e612082300, moduleTitle=Lancet Oncol：来曲唑治疗方案对早期乳腺癌患者无进展生存期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0e612082300)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378148, encodeId=037413e8148e9, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Eur Heart J：20年经验：实施循证治疗能否延长STEMI患者生存期？, objectType=article, longId=120230, objectId=e29d120230b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e29d120230b0, replyNumber=0, likeNumber=91, createdTime=2017-11-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e29d120230b0, moduleTitle=Eur Heart J：20年经验：实施循证治疗能否延长STEMI患者生存期？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e29d120230b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378147, encodeId=941613e8147d3, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Ann Oncol：当代化疗模式对晚期泌尿道癌患者生存期的影响：浸润性尿路上皮癌（RISC）的回顾性国际研究。, objectType=article, longId=118987, objectId=f6e211898e5f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e211898e5f, replyNumber=0, likeNumber=83, createdTime=2017-11-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e211898e5f, moduleTitle=Ann Oncol：当代化疗模式对晚期泌尿道癌患者生存期的影响：浸润性尿路上皮癌（RISC）的回顾性国际研究。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e211898e5f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378146, encodeId=faab13e8146a9, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JAMA Oncol：四个基因决定胰腺癌患者的生存期, objectType=article, longId=118811, objectId=05a8118811c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05a8118811c2, replyNumber=0, likeNumber=76, createdTime=2017-11-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05a8118811c2, moduleTitle=JAMA Oncol：四个基因决定胰腺癌患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05a8118811c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378145, encodeId=ffb513e8145c6, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=肿瘤治疗电场为复发性卵巢癌患者带来新希望，无进展生存期延长两倍！, objectType=article, longId=117443, objectId=670111e4433a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=670111e4433a, replyNumber=0, likeNumber=74, createdTime=2017-10-26, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=670111e4433a, moduleTitle=肿瘤治疗电场为复发性卵巢癌患者带来新希望，无进展生存期延长两倍！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=670111e4433a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378144, encodeId=5a5f13e8144bc, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Blood：Ixazomib显着延长复发性/难治性骨髓瘤患者的无进展生存期。, objectType=article, longId=117234, objectId=e31c11e2342c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e31c11e2342c, replyNumber=0, likeNumber=90, createdTime=2017-10-25, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e31c11e2342c, moduleTitle=Blood：Ixazomib显着延长复发性/难治性骨髓瘤患者的无进展生存期。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e31c11e2342c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378143, encodeId=e2b913e814354, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=【CSCO 2017】令人振奋：曲妥珠单抗治疗晚期胃癌生存期可达30个月, objectType=article, longId=114765, objectId=fa54114e6577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa54114e6577, replyNumber=0, likeNumber=89, createdTime=2017-09-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa54114e6577, moduleTitle=【CSCO 2017】令人振奋：曲妥珠单抗治疗晚期胃癌生存期可达30个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa54114e6577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378142, encodeId=a4aa13e8142ed, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Brit J Cancer：肿瘤种类、社会经济地位与患者生存期, objectType=article, longId=113135, objectId=5895113135a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5895113135a4, replyNumber=0, likeNumber=73, createdTime=2017-09-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5895113135a4, moduleTitle=Brit J Cancer：肿瘤种类、社会经济地位与患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5895113135a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378141, encodeId=33ea13e81413a, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=N Engl J Med：阿比特龙联合强的松能增加转移性去势敏感前列腺癌生存期, objectType=article, longId=111436, objectId=da13111436f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da13111436f9, replyNumber=0, likeNumber=49, createdTime=2017-09-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da13111436f9, moduleTitle=N Engl J Med：阿比特龙联合强的松能增加转移性去势敏感前列腺癌生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da13111436f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378140, encodeId=126d13e814042, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Ann Oncol：使用β－肾上腺素受体阻断剂能显著改善的HER2阴性的晚期乳腺癌患者的无进展生存期, objectType=article, longId=111335, objectId=5da0111335c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5da0111335c2, replyNumber=0, likeNumber=69, createdTime=2017-08-31, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5da0111335c2, moduleTitle=Ann Oncol：使用β－肾上腺素受体阻断剂能显著改善的HER2阴性的晚期乳腺癌患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5da0111335c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378139, encodeId=3be213e813994, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Clin Cancer Res：基于多参数磁共振影像组学预测晚期鼻咽癌患者无进展生存期, objectType=article, longId=111122, objectId=012d111122af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=012d111122af, replyNumber=0, likeNumber=117, createdTime=2017-08-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=012d111122af, moduleTitle=Clin Cancer Res：基于多参数磁共振影像组学预测晚期鼻咽癌患者无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=012d111122af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378138, encodeId=f0ff13e813890, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Gut：林奇综合征基因型对肿瘤风险和生存期的影响, objectType=article, longId=107351, objectId=cd4310e35166, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd4310e35166, replyNumber=0, likeNumber=84, createdTime=2017-08-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd4310e35166, moduleTitle=Gut：林奇综合征基因型对肿瘤风险和生存期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd4310e35166)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378137, encodeId=b1a413e813772, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=BMJ：结肠癌生存期预测影响因素, objectType=article, longId=105264, objectId=c352105264b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c352105264b5, replyNumber=0, likeNumber=86, createdTime=2017-07-13, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c352105264b5, moduleTitle=BMJ：结肠癌生存期预测影响因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c352105264b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378136, encodeId=f63f13e813638, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=BMJ：结直肠癌患者生存期预测：队列研究, objectType=article, longId=102567, objectId=276f10256ecc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=276f10256ecc, replyNumber=0, likeNumber=76, createdTime=2017-06-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=276f10256ecc, moduleTitle=BMJ：结直肠癌患者生存期预测：队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=276f10256ecc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378135, encodeId=121413e81351d, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Am J Clin Nutr：癌症患者代谢亢进影响恶液质和生存期！, objectType=article, longId=101222, objectId=5bc21012228f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5bc21012228f, replyNumber=0, likeNumber=124, createdTime=2017-06-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5bc21012228f, moduleTitle=Am J Clin Nutr：癌症患者代谢亢进影响恶液质和生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5bc21012228f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378134, encodeId=60f613e8134c8, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=SCI REP：治疗前的C-反应蛋白与白蛋白比值可以预测晚期胰腺癌患者的总体生存期！, objectType=article, longId=101094, objectId=fe6610109450, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe6610109450, replyNumber=0, likeNumber=87, createdTime=2017-06-09, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe6610109450, moduleTitle=SCI REP：治疗前的C-反应蛋白与白蛋白比值可以预测晚期胰腺癌患者的总体生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe6610109450)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378133, encodeId=130213e8133b4, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=ASCO:肺癌患者无进展生存期新药显著延长脑转移患者无进展生存期, objectType=article, longId=100969, objectId=8290100969be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8290100969be, replyNumber=0, likeNumber=83, createdTime=2017-06-08, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8290100969be, moduleTitle=ASCO:肺癌患者无进展生存期新药显著延长脑转移患者无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8290100969be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378132, encodeId=fcfc13e81320b, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=ASCO2017：肿瘤脑转移患者生存期影响因素, objectType=article, longId=100769, objectId=0909100e69fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0909100e69fb, replyNumber=0, likeNumber=123, createdTime=2017-06-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0909100e69fb, moduleTitle=ASCO2017：肿瘤脑转移患者生存期影响因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0909100e69fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378131, encodeId=475713e813101, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=全国营养科学大会：加大“带瘤生存期”营养干预, objectType=article, longId=99785, objectId=ba8e99e857c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba8e99e857c, replyNumber=0, likeNumber=113, createdTime=2017-05-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba8e99e857c, moduleTitle=全国营养科学大会：加大“带瘤生存期”营养干预, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba8e99e857c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378130, encodeId=837413e8130b7, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JCO：晚期非小细胞肺癌抗肿瘤治疗的方案、生存期和花费情况如何？, objectType=article, longId=99750, objectId=c44c99e50d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c44c99e50d9, replyNumber=0, likeNumber=77, createdTime=2017-05-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c44c99e50d9, moduleTitle=JCO：晚期非小细胞肺癌抗肿瘤治疗的方案、生存期和花费情况如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c44c99e50d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存期

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Lancet Oncol：来曲唑治疗方案对早期乳腺癌患者无进展生存期的影响

2017-11-22

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Eur Heart J：20年经验：实施循证治疗能否延长STEMI患者生存期？

2017-11-17

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Ann Oncol：当代化疗模式对晚期泌尿道癌患者生存期的影响：浸润性尿路上皮癌（RISC）的回顾性国际研究。

2017-11-08

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

JAMA Oncol：四个基因决定胰腺癌患者的生存期

2017-11-06

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

肿瘤治疗电场为复发性卵巢癌患者带来新希望，无进展生存期延长两倍！

2017-10-26

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Blood：Ixazomib显着延长复发性/难治性骨髓瘤患者的无进展生存期。

2017-10-25

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

【CSCO 2017】令人振奋：曲妥珠单抗治疗晚期胃癌生存期可达30个月

2017-09-30

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Brit J Cancer：肿瘤种类、社会经济地位与患者生存期

2017-09-20

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

N Engl J Med：阿比特龙联合强的松能增加转移性去势敏感前列腺癌生存期

2017-09-01

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Ann Oncol：使用β－肾上腺素受体阻断剂能显著改善的HER2阴性的晚期乳腺癌患者的无进展生存期

2017-08-31

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Clin Cancer Res：基于多参数磁共振影像组学预测晚期鼻咽癌患者无进展生存期

2017-08-30

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Gut：林奇综合征基因型对肿瘤风险和生存期的影响

2017-08-03

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

BMJ：结肠癌生存期预测影响因素

2017-07-13

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

BMJ：结直肠癌患者生存期预测：队列研究

2017-06-21

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Am J Clin Nutr：癌症患者代谢亢进影响恶液质和生存期！

2017-06-10

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

SCI REP：治疗前的C-反应蛋白与白蛋白比值可以预测晚期胰腺癌患者的总体生存期！

2017-06-09

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

ASCO:肺癌患者无进展生存期新药显著延长脑转移患者无进展生存期

2017-06-08

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

ASCO2017：肿瘤脑转移患者生存期影响因素

2017-06-07

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

全国营养科学大会：加大“带瘤生存期”营养干预

2017-05-28

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

JCO：晚期非小细胞肺癌抗肿瘤治疗的方案、生存期和花费情况如何？

2017-05-28

科室
- - 订阅+
  - 更多科室
工具
服务